BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27606815)

  • 1. Ocular manifestations of autoimmune polyendocrinopathy syndrome type 1.
    Couturier A; Brézin AP
    Curr Opin Ophthalmol; 2016 Nov; 27(6):505-513. PubMed ID: 27606815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keratopathy in Autoimmune Polyendocrinopathy Syndrome Type 1.
    Couturier A; Saugier-Veber P; Carel JC; Bertherat J; Brézin AP
    Cornea; 2015 Sep; 34(9):1086-91. PubMed ID: 26114819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal degeneration in autoimmune polyglandular syndrome type 1: a case series.
    Bourgault S; Baril C; Vincent A; Héon E; Ali A; MacDonald I; Lueder GT; Colleaux KM; Laliberté I
    Br J Ophthalmol; 2015 Nov; 99(11):1536-42. PubMed ID: 25926518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1.
    Meager A; Visvalingam K; Peterson P; Möll K; Murumägi A; Krohn K; Eskelin P; Perheentupa J; Husebye E; Kadota Y; Willcox N
    PLoS Med; 2006 Jul; 3(7):e289. PubMed ID: 16784312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular complications of autoimmune polyendocrinopathy syndrome type 1.
    Chang B; Brosnahan D; McCreery K; Dominguez M; Costigan C
    J AAPOS; 2006 Dec; 10(6):515-20. PubMed ID: 17189144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel and recurrent mutations in the AIRE gene of autoimmune polyendocrinopathy syndrome type 1 (APS1) patients.
    Faiyaz-Ul-Haque M; Bin-Abbas B; Al-Abdullatif A; Abdullah Abalkhail H; Toulimat M; Al-Gazlan S; Almutawa AM; Al-Sagheir A; Peltekova I; Al-Dayel F; Zaidi SH
    Clin Genet; 2009 Nov; 76(5):431-40. PubMed ID: 19758376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune polyendocrinopathy syndrome type 1 (APS1) and AIRE gene: new views on molecular basis of autoimmunity.
    Peterson P; Peltonen L
    J Autoimmun; 2005; 25 Suppl():49-55. PubMed ID: 16290093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of endothelin-converting enzyme-2 as an autoantigen in autoimmune polyendocrine syndrome type 1.
    Smith-Anttila CJA; Bensing S; Alimohammadi M; Dalin F; Oscarson M; Zhang MD; Perheentupa J; Husebye ES; Gustafsson J; Björklund P; Fransson A; Nordmark G; Rönnblom L; Meloni A; Scott RJ; Hökfelt T; Crock PA; Kämpe O
    Autoimmunity; 2017 Jun; 50(4):223-231. PubMed ID: 28557628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune polyendocrine syndrome type 1: an extensive longitudinal study in Sardinian patients.
    Meloni A; Willcox N; Meager A; Atzeni M; Wolff AS; Husebye ES; Furcas M; Rosatelli MC; Cao A; Congia M
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1114-24. PubMed ID: 22344197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BPIFB1 is a lung-specific autoantigen associated with interstitial lung disease.
    Shum AK; Alimohammadi M; Tan CL; Cheng MH; Metzger TC; Law CS; Lwin W; Perheentupa J; Bour-Jordan H; Carel JC; Husebye ES; De Luca F; Janson C; Sargur R; Dubois N; Kajosaari M; Wolters PJ; Chapman HA; Kämpe O; Anderson MS
    Sci Transl Med; 2013 Oct; 5(206):206ra139. PubMed ID: 24107778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The heterogeneity of autoimmune polyendocrine syndrome type 1: Clinical features, new mutations and cytokine autoantibodies in a Brazilian cohort from tertiary care centers.
    Weiler FG; Peterson P; Costa-Carvalho BT; de Barros Dorna M; Correia-Deur JE; Sader SL; Espíndola-Antunes D; Guerra-Junior G; Dias-da-Silva MR; Lazaretti-Castro M
    Clin Immunol; 2018 Dec; 197():231-238. PubMed ID: 30287219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TSGA10 - A target for autoantibodies in autoimmune polyendocrine syndrome type 1 and systemic lupus erythematosus.
    Smith CJ; Oscarson M; Rönnblom L; Alimohammadi M; Perheentupa J; Husebye ES; Gustafsson J; Nordmark G; Meloni A; Crock PA; Kämpe O; Bensing S
    Scand J Immunol; 2011 Feb; 73(2):147-53. PubMed ID: 21198756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune retinopathy in a patient with autoimmune polyendocrine syndrome type I.
    Breunig A; Lee MS; Miller BS; Binstadt BA; Anderson MS; Montezuma S
    Ocul Immunol Inflamm; 2013 Apr; 21(2):153-7. PubMed ID: 23697860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary autoantibodies in autoimmune polyendocrine syndrome type 1.
    Bensing S; Fetissov SO; Mulder J; Perheentupa J; Gustafsson J; Husebye ES; Oscarson M; Ekwall O; Crock PA; Hökfelt T; Hulting AL; Kämpe O
    Proc Natl Acad Sci U S A; 2007 Jan; 104(3):949-54. PubMed ID: 17215373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 1 Diabetes in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy Syndrome (APECED): A "Rare" Manifestation in a "Rare" Disease.
    Fierabracci A
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27420045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Longitudinal Follow-up of Autoimmune Polyendocrine Syndrome Type 1.
    Bruserud Ø; Oftedal BE; Landegren N; Erichsen MM; Bratland E; Lima K; Jørgensen AP; Myhre AG; Svartberg J; Fougner KJ; Bakke Å; Nedrebø BG; Mella B; Breivik L; Viken MK; Knappskog PM; Marthinussen MC; Løvås K; Kämpe O; Wolff AB; Husebye ES
    J Clin Endocrinol Metab; 2016 Aug; 101(8):2975-83. PubMed ID: 27253668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P450 1A2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1.
    Clemente MG; Obermayer-Straub P; Meloni A; Strassburg CP; Arangino V; Tukey RH; De Virgiliis S; Manns MP
    J Clin Endocrinol Metab; 1997 May; 82(5):1353-61. PubMed ID: 9141515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteome-wide survey of the autoimmune target repertoire in autoimmune polyendocrine syndrome type 1.
    Landegren N; Sharon D; Freyhult E; Hallgren Å; Eriksson D; Edqvist PH; Bensing S; Wahlberg J; Nelson LM; Gustafsson J; Husebye ES; Anderson MS; Snyder M; Kämpe O
    Sci Rep; 2016 Feb; 6():20104. PubMed ID: 26830021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aire deficient mice do not develop the same profile of tissue-specific autoantibodies as APECED patients.
    Pöntynen N; Miettinen A; Arstila TP; Kämpe O; Alimohammadi M; Vaarala O; Peltonen L; Ulmanen I
    J Autoimmun; 2006 Sep; 27(2):96-104. PubMed ID: 16820279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the autoimmune regulator gene in patients with autoimmune non-APECED polyendocrinopathies.
    Palma A; Gianchecchi E; Palombi M; Luciano R; Di Carlo P; Crinò A; Cappa M; Fierabracci A
    Genomics; 2013 Sep; 102(3):163-8. PubMed ID: 23643663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.